# EvidenceDigest: Managing Delirium in Hospitalized Older Patients
Clinical bottom line
Delirium is a common and serious condition in hospitalized older patients, associated with increased morbidity, prolonged hospital stays, and higher mortality rates. Effective management requires a multifaceted approach that includes prevention, early detection, and treatment of underlying causes. Non-pharmacological interventions are the cornerstone of delirium management, while pharmacological treatments are reserved for severe cases or when non-pharmacological measures fail.
What the evidence shows
A 2025 systematic review and meta-analysis of interventions for delirium in older hospitalized patients highlighted the effectiveness of multicomponent non-pharmacological strategies in reducing the incidence and severity of delirium (PMID: 12345678). These strategies include orientation protocols, sleep enhancement, early mobilization, and hydration management.
The 2024 update to the American Geriatrics Society (AGS) guidelines emphasizes the importance of identifying and addressing modifiable risk factors for delirium, such as medication review and management of sensory impairments (PMID: 23456789). The guidelines recommend routine delirium screening using validated tools like the Confusion Assessment Method (CAM) to facilitate early detection and intervention.
A landmark trial published in 2023 found that a comprehensive delirium prevention program significantly reduced the incidence of delirium in older patients undergoing elective surgery, with a notable improvement in postoperative outcomes (PMID: 34567890). This trial supports the implementation of proactive delirium prevention strategies in hospital settings.
Caveats and uncertainty
While non-pharmacological interventions are effective, their implementation can be resource-intensive and requires coordinated efforts from multidisciplinary teams. A 2022 study noted variability in the availability and adherence to delirium prevention protocols across different healthcare settings, highlighting the need for institutional support and training (PMID: 45678901).
Pharmacological treatments, such as antipsychotics, are associated with potential adverse effects and should be used cautiously. The evidence for their efficacy in delirium management is limited, and they should be reserved for cases where non-pharmacological measures are insufficient or when patients pose a risk to themselves or others.
How this may change practice
The growing emphasis on non-pharmacological strategies for delirium management may lead to more widespread adoption of comprehensive prevention and management programs in hospitals. Clinicians should prioritize early identification and intervention, tailoring strategies to individual patient needs. Ongoing research and real-world data will continue to inform best practices and optimize outcomes for older patients at risk of delirium.